GlassScriptPhysician profile
Jaewon Lee
NPI 1467941401
$1,716.23
in general payments reported to CMS, 2019-2025
16 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $266 · 2023: $563 · 2024: $675 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,449.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $603.50 | 2022-2024 | Epclusa, Descovy, Biktarvy |
| Viiv Healthcare Company | $245.79 | 2022-2023 | Apretude |
| Novo Nordisk INC | $165.79 | 2023-2025 | Wegovy, Ozempic |
| Madrigal Pharmaceuticals | $144.13 | 2024 | Rezdiffra |
| Abbvie INC. | $125.00 | 2024 | |
| Indivior INC. | $98.18 | 2023-2025 | Sublocade |
| Braeburn INC. | $93.10 | 2024 | Brixadi |
| Pfizer INC. | $47.26 | 2023-2024 | |
| Lilly USA, LLC | $31.97 | 2025 | Mounjaro |
| Glaxosmithkline, LLC. | $29.53 | 2024 | Bexsero |
| Corcept Therapeutics | $28.01 | 2025 | Korlym |
| Dexcom, INC. | $24.92 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $22.36 | 2025 | The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $20.64 | 2022 | |
| Amgen INC. | $18.95 | 2024 | Repatha |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $17.10 | 2023 | Vivitrol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaewon Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.